Momentum

Significant increase in HIV PrEP awareness does not correspond with use

Researchers in Canada have tracked a significant increase in awareness of HIV pre-exposure prophylaxis, or PrEP, although low rates of actual use were reported in the Momentum Health Study. Nathan Lachowsky, PhD, assistant professor at the University of Victoria School of Public Health and Social Policy in British Columbia, and colleagues evaluated responses to a

Significant increase in HIV PrEP awareness does not correspond with use Read More »

Q&A with Dr. Nate Lachowsky: Study shows 4 out of 5 gay, bi and men who have sex with men are aware of HIV prevention drug, PrEP

A new study shows most of gay, bi, men who have sex with men (MSM) and other MSM, are aware of PrEP (pre-exposure prophylaxis) – an HIV prevention drug recently made available at no charge to British Columbians at risk of HIV.

Q&A with Dr. Nate Lachowsky: Study shows 4 out of 5 gay, bi and men who have sex with men are aware of HIV prevention drug, PrEP Read More »

4 out of 5 gay, bi and men who have sex with men are aware of HIV prevention drug, PrEP

Indigenous, Latino, bisexual and single men less likely to be aware of newly publicly-funded HIV prevention medication (Vancouver, January 31, 2018) A new study shows most of gay, bi, men who have sex with men (MSM) and other MSM, are aware of PrEP (pre-exposure prophylaxis) – an HIV prevention drug recently made available at no

4 out of 5 gay, bi and men who have sex with men are aware of HIV prevention drug, PrEP Read More »

New research finds Over 40% percent of gay and bisexual men in Metro Vancouver are smokers

New research from the Momentum Health Study, a program supported by the BC Centre for Excellence in HIV/AIDS, finds rates of smoking are three times higher among gay and bisexual men compared to the general population in a province that has the lowest rates of smoking in the country.

New research finds Over 40% percent of gay and bisexual men in Metro Vancouver are smokers Read More »

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below